Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients
NCT ID: NCT00478582
Last Updated: 2011-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2007-05-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of the present investigation is to validate the use of a Hb visual scale for the clinical evaluation of anemia in patients with kidney disease patients
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Association Between the Distributions MCH and RBC, and Mortality in Hemodialysis Patients
NCT04227158
Mean Reticulated Haemoglobin (Hb) Content (RetHe) Analysis of Renal Patients
NCT01126905
Intravenous Iron in Patients With Anemia of Chronic Kidney Disease
NCT00204256
Renal Anemia Refractory to Erythropoietin
NCT03480178
Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients
NCT02198495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Estimation of Hb concentrations with the HemoHue card
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dominik Uehlinger, Prof
Role: STUDY_DIRECTOR
Dominik Uelinger, Prof
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of nephrology and hypertension, University hospital of berne
Bern, Canton of Bern, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HB 5/2007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.